What is the recommended bilastine dose for adults, adolescents, and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bilastine Dosing Recommendations

For adults and adolescents ≥12 years, bilastine 20 mg once daily is the standard dose; for children aged 6-11 years, 10 mg once daily is recommended; and for children aged 2-5 years (where approved), 10 mg once daily is also appropriate. 1

Age-Specific Dosing

Adults and Adolescents (≥12 years)

  • Standard dose: 20 mg once daily 2
  • This dose has been extensively validated for allergic rhinoconjunctivitis and urticaria
  • No dosage adjustments needed for renal or hepatic impairment, or in elderly patients 2

Children 6-11 Years

  • 10 mg once daily 1, 3
  • Pharmacokinetic studies confirm that this pediatric dose achieves similar plasma exposure to the adult 20 mg dose (median pediatric/adult ratios for AUC and Cmax were 0.93 and 0.91, respectively) 3
  • Safety profile comparable to placebo in this age group 3

Children 2-5 Years

  • 10 mg once daily 1, 4
  • Approved in select regions (Mexico, some African countries) for children ≥2 years 5
  • Pharmacokinetic modeling demonstrates that body weight and age do not significantly affect drug clearance or distribution in this age range, supporting the 10 mg dose across the 2-11 year age spectrum 4
  • Peak plasma concentrations occur approximately 1 hour after administration 4

Children 4-11 Years (Specific Weight Criteria)

  • For children weighing ≥16 kg aged 4-11 years: 10 mg once daily 1
  • This weight-based criterion is particularly relevant in certain regulatory jurisdictions (Canada approves ≥4 years; Europe approves ≥6 years) 5

Formulation Considerations

Bilastine is available as:

  • Orodispersible tablets for pediatric use 4
  • Standard tablets for adults and adolescents 2

Important Clinical Caveats

Timing with food: Bilastine absorption is affected by food intake. While not explicitly detailed in the provided guidelines, standard practice recommends administration 1 hour before or 2 hours after meals for optimal absorption.

Up-dosing in refractory urticaria: The 2025 CSU guidelines recommend considering up-dosed second-generation antihistamines (2-4 times the approved dose) if standard dosing fails to control symptoms 1. For bilastine, this would translate to 40-80 mg daily in adults, though this is off-label use.

Drug interactions: Bilastine undergoes negligible metabolism and does not interact with the CYP450 system, minimizing drug-drug interaction potential 2. It is a P-glycoprotein substrate, which actually limits CNS penetration and reduces sedation risk 6.

Safety profile: Bilastine demonstrates no anticholinergic effects, no cardiotoxicity, minimal CNS penetration, and does not enhance alcohol effects 2, 6. Treatment-emergent adverse events in children are comparable to placebo 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.